| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diabetes > Diabetes - Glucose Treatment - The Newest Miracle for Diabetes |
|
Advice Pool - Diabetes - Glucose Treatment - The Newest Miracle for Diabetes
There is no cure or any specific treatment for diabetes. The best thing that you can do is to control it. Complications and severe attacks caused by the disease can be prevented with proper management of medications According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product and diet programs. Before talking about glucose treatment and what its benefits are, it is best to know all the other treatments available for the treatment of diabetics. Many studies and research have been done to ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in study the effects of the disease in an attempt to totally eradicate it. The closest one can get to being free from this illness is to undergo a pancreatic transplant but this is a last resort measure as diabetes can lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. be controlled effectively. There is a vast range of diabetes pills on the market today. Examples are: Sulfonylureas (which helps in stimulating your pancreas to create insulin); Biguanides (which decreases the gluco here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e that is produced by your liver); Alpha-glucosidase inhibitors (these slow down starch absorption); Thiazolidinediones (this medicine helps you become more receptive to insulin); Meglitinides (much like the Sulfonylu d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro eas, they can stimulate the creation of insulin by your pancreas); D-phenylalanine derivatives (these do not only stimulate but hasten the creation of insulin by the pancreas); Combination Oral Medicines (this simply ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc means you put together varying types of pills for better results). Now there's glucose treatment. Glucose, to begin with, is a monosaccharide that can also be used to control blood sugar levels. This is an over-the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi counter product that can be used by anyone, even pregnant or lactating women. This can be bought in gel or chewable tablet form. Oral glucose treatment has short-term effects. Upon an attack, it can help in stabiliz nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ng the patient. However, there is a form of glucose treatment that can produce long-term effects. The latest study for the treatment of diabetes is the so-called glucose treatment, sometimes called glucose therapy. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ The goal of this study is to know whether neonatal infusion of glucose would have a positive influence on patients. Glucose treatment was primarily tested among lab rats to see if it could help alleviate the effects ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi f diabetes. The initial tests done with the lab rats showed promising results. First, there were thirty-nine rats that had to undergo this experiment. Nineteen of these rats were male and the rest (20) were all fem ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a les. This group served as the experimental group. The objective was, for the rats' first six days of life, they would be injected twice in a day with 8 grams of glucose/kilogram BW/day. There was also a second grou dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod p of rats that served as the control group (20 male rats and 16 female rats). They, unlike the first group, remained untreated. The result? After the 6 experimental days, 16% of the treated males became diabetics a cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin compared to the staggering 50% among the ones who were not infused with glucose. As with the females, 50% of the treated females acquired diabetes as compared to the 69% of the untreated batch. With this data, it w tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s concluded that glucose treatment could be very valuable and could help reduce diabetes in humans. And, of course, humans were next to be tested. The scientists wanted to conclude that glucose treatment could also t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel be beneficial to humans. With the human study, glucose infusion was done, not with injections, but through IV's. One woman was reported to have stated that before the glucose treatments, she spent countless days and ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust months in the hospital. She said that she never had a social life because her disease prevented her from living a normal life. With this same subject, she reported that there was even a time when she was hospitalize y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products for a total of 30 times within just 3 months! This would definitely drive anyone to try all the types of available treatments there is. This patient's treatment included having home infusions but she did not mind. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de When she stuck with her regular glucose treatment, improvement soon became evident. She had an improved disposition and had no more acute attacks. To add to that, she has not been hospitalized since she underwent t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e glucose treatment! It was, for her, a chance for a new life. Diabetes and glucose treatment is nothing but good news to all diabetics. Maybe this is the beginning of an era where diabetes is no longer untreatable tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Find And Select The Best Debt Consolidation Company? Enjoy Your Christmas Thoroughly! Backup Your Data Files! What are the Potential Complications of Cosmetic Eyelid Surgery?
|